Neuland Labs: Certificate Under SEBI Reg. 74(5) For Q4FY26 Filed
Neuland Laboratories Limited has filed a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The company's Registrar and Share Transfer Agent, Kfin Technologies Limited, confirmed that dematerialization/rematerialization details were submitted to stock exchanges and depositories.
This is a standard compliance filing regarding dematerialization of shares, which is a routine procedural update and is unlikely to have any significant impact on the company's stock or business operations.
The announcement is a routine regulatory filing and does not contain any new financial information or strategic updates that would indicate a positive or negative sentiment.
Neuland Laboratories Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended March 31, 2026.
The company received this certification from its Registrar and Share Transfer Agent, Kfin Technologies Limited. The certificate confirms that the details of securities dematerialized/rematerialized during the said quarter have been furnished to all the stock exchanges where Neuland Laboratories Limited's shares are listed, including BSE Limited and the National Stock Exchange of India Ltd.
Kfin Technologies Limited, acting as the Registrar and Share Transfer Agent, has certified that the required information has been provided to both Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL). The communication was dated April 1, 2026.
What to do with a filing like this
Neuland Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neuland Laboratories Limited. Read the original for the full detail.